Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Graber

Showing results (31-40 of 140) with videos related to

Pageof 14
Sort By:
Lancet (London, England)|December 4, 1976
Agranulocytosis due to levamisoleH Graber, L Takacs, K Vedrödy
Therapia Hungarica (English Edition)|January 1, 1971
Clinical evaluation of the analgesic effect of Probon (MZ-114)H Graber, P Szentmiklósi, J Krepuska
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
Clinical efficacy of roxithromycin in respiratory tract infectionsE Ludwig, H Graber, Z Bárándy, et al.
Drugs|January 1, 1988
Pharmacokinetics of cefotaxime and desacetylcefotaxime in elderly patientsE Ludwig, E Székely, A Csiba, et al.
Frontiers in Immunology|February 10, 2023
Macrophage differentiation is marked by increased abundance of the mRNA 3' end processing machinery, altered poly(A) site usage, and sensitivity to the level of CstF64Srimoyee Mukherjee, Joel H Graber, Claire L Moore
BMC Genomics|March 18, 2006
A multispecies comparison of the metazoan 3'-processing downstream elements and the CstF-64 RNA recognition motifJesse Salisbury, Keith W Hutchison, Joel H Graber
Orvosi Hetilap|December 14, 1975
[Studies on the interaction of nalidixic acid and oxolinic acid]E Ludwig, H Graber, T Perényi, et al.
International Journal of Clinical Pharmacology and Biopharmacy|February 1, 1978
Pharmacokinetic and clinical studies with carfecillinH Graber, L Benesch, M Arr, et al.
Orvosi Hetilap|September 19, 1982
[Pharmacokinetics of tobramycin (Brulamycin) in young and old age]E Ludwig, M Arr, T Magyar, et al.
The Journal of the Kansas Medical Society|March 19, 2010
Typhoid carrier state; treatment by cholecystectomyS L STOUT, C T McCOY, H GRABER
Pageof 14

Showing results (31-40 of 140) with videos related to

Sort By:
Pageof 14
Lancet (London, England)|December 4, 1976
Agranulocytosis due to levamisoleH Graber, L Takacs, K Vedrödy
Therapia Hungarica (English Edition)|January 1, 1971
Clinical evaluation of the analgesic effect of Probon (MZ-114)H Graber, P Szentmiklósi, J Krepuska
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
Clinical efficacy of roxithromycin in respiratory tract infectionsE Ludwig, H Graber, Z Bárándy, et al.
Drugs|January 1, 1988
Pharmacokinetics of cefotaxime and desacetylcefotaxime in elderly patientsE Ludwig, E Székely, A Csiba, et al.
Frontiers in Immunology|February 10, 2023
Macrophage differentiation is marked by increased abundance of the mRNA 3' end processing machinery, altered poly(A) site usage, and sensitivity to the level of CstF64Srimoyee Mukherjee, Joel H Graber, Claire L Moore
BMC Genomics|March 18, 2006
A multispecies comparison of the metazoan 3'-processing downstream elements and the CstF-64 RNA recognition motifJesse Salisbury, Keith W Hutchison, Joel H Graber
Orvosi Hetilap|December 14, 1975
[Studies on the interaction of nalidixic acid and oxolinic acid]E Ludwig, H Graber, T Perényi, et al.
International Journal of Clinical Pharmacology and Biopharmacy|February 1, 1978
Pharmacokinetic and clinical studies with carfecillinH Graber, L Benesch, M Arr, et al.
Orvosi Hetilap|September 19, 1982
[Pharmacokinetics of tobramycin (Brulamycin) in young and old age]E Ludwig, M Arr, T Magyar, et al.
The Journal of the Kansas Medical Society|March 19, 2010
Typhoid carrier state; treatment by cholecystectomyS L STOUT, C T McCOY, H GRABER
Pageof 14